MENU
EVO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Evotec SE (EVO) Ownership - Who owns Evotec SE?
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations... Show more
Profile
Industry
N/A
Address
Essener Bogen 7
Phone
+49 40560810
Employees
4952
Web
https://www.evotec.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.33B
P/E Ratio
N/A
Total Cash
378.71M
Projected Growth
N/A
Total Debt
60.92M
Revenue
788.22M
Risk (Beta)
1.92
Dividend Yield
N/A
Total Cash/Share
1.07
Total Debt/Equity
N/A
Revenue/Share
2.57 USD as % of share price
Fundamentals
EVO
Capitalization
1.33B
P/E Ratio
N/A
Risk (Beta)
1.92
Dividend Yield
N/A
Total Cash
379M
Total Cash/Share
1.07
Total Debt
60.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.57%
Revenue
788M
ROE
N/A
Book Value
912M
P/B Ratio
1.35
Cash Flow
N/A
Earnings
-0.59
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
178M
Current Ratio
2.03
Current Revenue Per Employee
41959.30
Dividends Per Share - Security
N/A
EBITDA
-185.61M
Float
N/A
Float - Current
N/A
Gross Income Margin
13.61
Revenue To Assets
-9.97
Shares Held By Institutions
82.1M
Shares Outstanding - Current
355M
Total Liabilities
1.03B
Total Volume MTD
N/A
Value
-1
Gain YTD
-9.615
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EVO showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
N/A
Address
Essener Bogen 7
Phone
+49 40560810
Employees
4952
Web
https://www.evotec.com